Merck Begins Tender Offer to Acquire Pandion Therapeutics
Go back to Merck Begins Tender Offer to Acquire Pandion Therapeutics| Merck & Co. (NYSE: MRK) | Delayed: 151.64 +1.78 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.86 | 52 Week High | $65.46 | |||
| Open | $151.50 | 52 Week Low | $47.97 | |||
| Day High | $152.69 | P/E | 103.16 | |||
| Day Low | $149.97 | EPS | $1.47 | |||
| Volume | 8,970,590 | |||||
| (NASDAQ: PAND) | Delayed: 60.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.05 | 52 Week High | $ | |||
| Open | $35.76 | 52 Week Low | $ | |||
| Day High | $60.05 | P/E | N/A | |||
| Day Low | $60.05 | EPS | $ | |||
| Volume | 1,360 | |||||
